Envoy Medical, Inc. (COCH)
0.71
-0.02
(-2.75%)
USD |
NASDAQ |
Sep 04, 16:00
0.7033
-0.01
(-0.94%)
After-Hours: 20:00
Envoy Medical Research and Development Expense (Quarterly) : 3.132M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.132M |
| March 31, 2026 | 3.642M |
| December 31, 2025 | 4.553M |
| September 30, 2025 | 2.70M |
| June 30, 2025 | 2.485M |
| March 31, 2025 | 2.748M |
| December 31, 2024 | 2.471M |
| September 30, 2024 | 2.757M |
| Date | Value |
|---|---|
| June 30, 2024 | 2.591M |
| March 31, 2024 | 2.36M |
| December 31, 2023 | 3.055M |
| September 30, 2023 | 1.85M |
| June 30, 2023 | |
| March 31, 2023 | 1.927M |
| December 31, 2022 | 1.443M |
| September 30, 2022 | 0.935M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Electromed, Inc. | 0.328M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| ResMed, Inc. | 105.73M |